Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(17%)
Results Posted
100%(3 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_2
5
83%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
5(83.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Terminated2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 25 (83.3%)
Phase 41 (16.7%)

Trials by Status

terminated233%
recruiting117%
completed350%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_4

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

NCT06571825
completedphase_2

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

NCT01814488
terminatedphase_2

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

NCT00096460
completedphase_2

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

NCT00506129
terminatedphase_2

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior

NCT01588951
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06571825Phase 4

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Recruiting
NCT01814488Phase 2

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

Completed
NCT00096460Phase 2

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

Terminated
NCT00506129Phase 2

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Completed
NCT01588951Phase 2

Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior

Terminated
NCT01034449Phase 2

Transplantation of Ex-vivo Expanded Cord Blood Stems Cells

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6